0
1600
Despite Bladder Cancer Risk, European Medicines Agency Does Not Recall Actos
Despite a reported link to an increased risk of bladder cancer, European drug regulators have determined that a recall of the diabetes drug Actos is not necessary. On October 21, 2011 the European Medicines Agency issued a clarification of its... Read more






